Valvular Heart Failure due to Tricuspid Regurgitation: Surgical and Transcatheter Management Options

Mark A Lebehn; Rebecca T Hahn

doi:10.1016/j.hfc.2023.02.003

Valvular Heart Failure due to Tricuspid Regurgitation: Surgical and Transcatheter Management Options

Heart Fail Clin. 2023 Jul;19(3):329-343. doi: 10.1016/j.hfc.2023.02.003. Epub 2023 Apr 7.

Authors

Mark A Lebehn¹, Rebecca T Hahn²

Affiliations

¹ Department of Medicine, Columbia University Medical Center/NY Presbyterian Hospital, New York, USA.
² Department of Medicine, Columbia University Medical Center/NY Presbyterian Hospital, New York, USA. Electronic address: rth2@columbia.edu.

PMID: 37230648
DOI: 10.1016/j.hfc.2023.02.003

Abstract

Given the independent association of mortality with higher grades of tricuspid regurgitation severity, there is an increasing interest in improving the outcomes of this prevalent valvular heart disease. A new classification of tricuspid regurgitation etiology allows for an improved understanding of different pathophysiologic forms of the disease, which may determine the appropriate management strategy. Current surgical outcomes remain suboptimal and multiple transcatheter device therapies are currently under investigation to give high and prohibitive surgical risk patients treatment options beyond medical therapy.

Keywords: Echocardiography; Heart failure; Transcatheter tricuspid valve devices; Tricuspid regurgitation; Tricuspid valve surgery.

Publication types

Review

MeSH terms

Cardiac Catheterization / adverse effects
Heart Failure* / etiology
Heart Failure* / therapy
Heart Valve Prosthesis Implantation* / adverse effects
Humans
Treatment Outcome
Tricuspid Valve / surgery
Tricuspid Valve Insufficiency* / etiology
Tricuspid Valve Insufficiency* / surgery